COMMENTARY: Prophylactic implantable cardioverter--defibrillators increased life expectancy with an acceptable cost-effectiveness ratio

Hillegass, William B.; McElderry Jr., Hugh T.
March 2006
ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p52
Academic Journal
This article reports that cardiovascular medicine is at the threshold of moving from an era of scientific and technical limitations to an era of economic limitation. Prophylactic implantable cardioverter--defibrillators (ICD) therapy stands as a stark test of how scientific, political, and economic forces will resolve this threshold in the U.S. and elsewhere. Researchers accurately summarize the clinical data in the form of cost-effectiveness analysis. Prophylactic ICD placement, in patients without documented ventricular arrhythmia but with significant left ventricular systolic dysfunction, increases average life expectancy by 2.1 to 6.2 undiscounted years.


Related Articles

  • Implantable cardioverter defibrillator as a bridge to recovery in an infant with cardiac rhabdomyoma. Chockalingam, Priya; Clur, Sally-Ann B.; Wilde, Arthur A. M.; Kuipers, Irene; Van Woensel, Job; Blom, Nico A. // European Journal of Pediatrics;Jul2009, Vol. 168 Issue 7, p863 

    Multiple cardiac rhabdomyomas in an infant presented with recurrent life-threatening ventricular arrhythmias refractory to medical treatment and necessitating the placement of an implantable cardioverter defibrillator (ICD). The device functioned effectively as a bridge to recovery during a...

  • Historia familiar de muerte súbita por fibrilación ventricular idiopática. Dorantes, Margarita; Marrero, Roberto; Méndez, Annerys; Castroa, Jesús; Vázquez, Alfredo // Archivos de Cardiología de México;ene-mar2014, Vol. 84 Issue 1, p57 

    No abstract available.

  • Prevention of inadequate shocks in children and adolescents, treated with implantable cardioverters.  // Cardiology in the Young;May2005 Supplement 2, Vol. 15 Issue S2, p46 

    This article focuses on a study related to the prevention of inadequate shocks in children and adolescents, treated with implantable cardioverters (ICD). ICD's are available for the treatment of life threatening ventricular arrhythmias in children and adolescents. Devices have been optimized...

  • Antiarrhythmic Therapy of Ventricular Arrhythmias: The Contemporary Dilemma. Singh, Bramah N. // Journal of Cardiovascular Pharmacology & Therapeutics;Mar1996, Vol. 1 Issue 1, p3 

    The author reflects on a variety of issues concerning the use of antiarrhythmic therapy for ventricular arrhythmias. He cites the effect of implantable cardioverter defibrillators (ICD) on mortality rate. He discusses three articles concerning the clinical management of ventricular arrhythmias....

  • Single versus dual chamber implantable cardioverter defibrillator for the avoidance of inappropriate shocks - results from the OPTION trial. Kolb, Christof // Cardiologia Croatica;Mar/Apr2014, Vol. 9 Issue 3/4, p91 

    Introduction: Implantable Cardioverter Defibrillators (ICD) are considered to be the treatment of choice for primary and secondary prevention of sudden cardiac death. However, the therapy is burdened by inappropriate ICD shocks (for example for supraventricular tachyarrhythmias) which reduce...

  • Prophylactic implantable cardioverter--defibrillators increased life expectancy with anacceptable cost-effectiveness ratio.  // ACP Journal Club;Mar/Apr2006, Vol. 144 Issue 2, p52 

    This article presents a study which reveals that Prophylactic implantable cardioverter--defibrillators (ICD) increased life expectancy with anacceptable cost-effectiveness ratio. Patients at risk for sudden death because of left ventricular systolic dysfunction who had not had life-threatening...

  • Effect of Fish Oil on Ventricular Tachyarrhythmia and Death in Patients With Implantable Cardioverter Defibrillators. Brouwer, Ingeborg A.; Zock, Peter L.; Camm, A. John; Böcker, Dirk; Hauer, Richard N. W.; Wever, Eric F. D.; Dullemeijer, Carla; Ronden, Jacintha E.; Katan, Martijn B.; Lubinski, Andrzej; Buschler, Helga; Schouten, Evert G. // JAMA: Journal of the American Medical Association;6/14/2006, Vol. 295 Issue 22, p2613 

    This article presents a study examining the effects of fish oil on ventricular tachyarrhythmia and subsequent death in patients with implantable cardioverter defibrillators. The study involved two groups of patients with implantable cardioverter-defibrillators across 26 cardiology clinics,...

  • Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both. Solomon, Scott D.; Zelenkofske, Steve; McMurray, John J.V.; Finn, Peter V.; Velazquez, Eric; Ertl, George; Harsanyi, Adam; Rouleau, Jean L.; Maggioni, Aldo; Kober, Lars; White, Harvey; Van de Werf, Frans; Pieper, Karen; Califf, Robert M.; Pfeffer, Marc A. // New England Journal of Medicine;6/23/2005, Vol. 352 Issue 25, p2581 

    Background: The risk of sudden death from cardiac causes is increased among survivors of acute myocardial infarction with reduced left ventricular systolic function. We assessed the risk and time course of sudden death in high-risk patients after myocardial infarction. Methods: We studied 14,609...

  • Infarct size and recurrence of ventricular arrhythmias after defibrillator implantation. De Sutter, Johan; Tavernier, Rene; Van de Wiele, Christophe; Kazmierckzak, Jaroslaw; De Buyzere, Marc; Jordaens, Luc; Clement, Denis L.; Dierckx, Rudi A // European Journal of Nuclear Medicine;2000, Vol. 27 Issue 7, p807 

    Abstract. Infarct size as determined by perfusion imaging is an independent predictor of mortality after implantable cardioverter defibrillator (ICD) implantation in patients with coronary artery disease (CAD) and life-threatening ventricular arrhythmias (VA). However, its value as a predictor...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics